InsiderTrades

Willard Stephen H

SEC CIK 1325232 · EDGAR

Buying vs selling by month open-market trades, last 46 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
LGVNLongeveron Inc.CEO 771.7K — — 52026-03-022026-07-01
NRXPNRX Pharmaceuticals, Inc.CEO, Dir 50.0K $58.5K — 12022-12-162022-12-16

Most active insiders at LGVN, 12 months

#InsiderTitleBoughtSold
1 Paletta George A. Jr.Dir ——
2 Powell James NathanielCEO ——
3 Blass DevinCTO, SVP of CMC ——
4 Hajjar Roger JosephDir ——
5 Jhaveri Nirav S.CFO ——
6 Locklear LisaCFO ——
7 Agafonova NataliyaChief Medical Off ——
8 Desai Arjun JJDir ——
9 Ungaro UrsulaDir ——
10 Lehr Paul TGC, Sec ——
15 Willard Stephen HCEO ——

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2026-07-06 20:55 2026-07-01 LGVN Longeveron Inc. Willard Stephen H CEO F - Tax $0.7291 -18.0K 771.7K -2% -$13.2K
2026-05-05 18:00 2026-05-01 LGVN Longeveron Inc. Willard Stephen H CEO A - Grant $0.00 +500.0K 789.7K +173% $0
2026-04-03 17:00 2026-04-01 LGVN Longeveron Inc. Willard Stephen H CEO F - Tax $1.12 -4,740 289.7K -2% -$5,309
DM 2026-03-13 2026-03-02 LGVN Longeveron Inc. Willard Stephen H CEO A - Grant $0.00 +400.0K 200.0K New $0
D 2026-03-13 2026-03-02 LGVN Longeveron Inc. Willard Stephen H CEO F - Tax $0.55 -105.5K 94.5K -53% -$58.0K
2022-12-19 2022-12-16 NRXP NRX Pharmaceuticals, Inc. Willard Stephen H CEO, Dir P - Purchase $1.17 +50.0K 50.0K New +$58.5K

Purchase Sale Sale after option exercise All abbreviations